SEC Form 4 · accession 0001209191-17-051110
LEMAITRE VASCULAR INC · LMAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David B Roberts
Officer — President and Director · Director
Period of report
Aug 30, 2017
Accepted (ET)
Sep 1, 2017 · 8:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001158895
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 30, 2017 | M | 19,503 | $11.43 | A | 48,108 | D | |
| Common StockF1 | Aug 30, 2017 | M | 7,180 | $14.13 | A | 55,288 | D | |
| Common StockF2 | Aug 30, 2017 | S | 26,683 | $36.6705 | D | 28,605 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $11.43 | Aug 30, 2017 | M | 19,503 | D | Jul 23, 2015 | Jul 23, 2022 | Common Stock | 19,503 | 29,255 | D |
| Stock Option (Right to Buy)F3 | $14.13 | Aug 30, 2017 | M | 7,180 | D | Jul 25, 2016 | Jul 25, 2023 | Common Stock | 7,180 | 35,796 | D |
Explanation of responses
- F1Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
- F2The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $36.52 to $37.17. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- F3This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years.